BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36716258)

  • 1. Emerging trends in the prediction of pathological tumour response in rectal cancer following neoadjuvant therapy.
    Wei MY; Arafat Y; Lee M; Kosmider S; Loft M; Faragher I; Gibbs P; Yeung JM
    ANZ J Surg; 2023 Oct; 93(10):2285-2286. PubMed ID: 36716258
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.
    Ryan JE; Warrier SK; Lynch AC; Heriot AG
    Colorectal Dis; 2015 Oct; 17(10):849-61. PubMed ID: 26260213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Ho SSK; Hon SSF; Hung E; Lee JFY; Mo F; Tong M; So C; Chu S; Ng DCK; Lam D; Cho C; Mak TWC; Ng SSM; Futaba K; Suen J; To KF; Chan AWH; Yeung WWK; Ma BBY
    Hong Kong Med J; 2022 Jun; 28(3):230-238. PubMed ID: 35667869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.
    Runau F; Collins A; Fenech GA; Ford E; Dimitriou N; Chaudhri S; Yeung JM
    Int J Colorectal Dis; 2017 Mar; 32(3):341-348. PubMed ID: 27885480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application value of biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in preoperative T staging after neoadjuvant chemoradiotherapy for rectal cancer.
    Xiao Y; Xu D; Ju H; Yang C; Wang L; Wang J; Hazle JD; Wang D
    Eur J Radiol; 2018 Jul; 104():20-25. PubMed ID: 29857861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case report of locally recurrent rectal cancer after low anterior resection that led to a pathological complete response to neoadjuvant chemoradiotherapy].
    Matsushita A; Takemoto H; Ikeda M; Munakata T; Fukunaga M; Kawabata R; Yamamoto T; Oda K; Kishimoto T; Imamura H; Ohzato H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2261-3. PubMed ID: 23268043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.
    Garland ML; Vather R; Bunkley N; Pearse M; Bissett IP
    Int J Colorectal Dis; 2014 Mar; 29(3):301-7. PubMed ID: 24420737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
    Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
    BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Author response: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Wu Q; He Y; Wang Z
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 37995277
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of differentiation and T stage can predict unresponsiveness to neoadjuvant therapy for rectal cancer.
    Qiu HZ; Wu B; Xiao Y; Lin GL
    Colorectal Dis; 2011 Dec; 13(12):1353-60. PubMed ID: 21689282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of clinical evaluation of response to neoadjuvant chemoradiation therapy for rectal cancer.
    Benzoni E; Cerato F; Cojutti A; Milan E; Pontello D; Chiaulon G; Sacco C; Bresadola V; Terrosu G
    Tumori; 2005; 91(5):401-5. PubMed ID: 16459636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two Cases of Pathological Complete Response with Neoadjuvant Therapy for Advanced Rectal Cancer].
    Matsuda C; Danno K; Miyazaki S; Fujitani K; Kubota M; Motoori M; Nakatsuka R; Okumura Y; Nomura M; Nishimura M; Kitagawa A; Matsuura N; Fushimi H; Iwase K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2313-5. PubMed ID: 26805348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Zhang W; Huang J
    Br J Surg; 2024 Jan; 111(1):. PubMed ID: 37995275
    [No Abstract]   [Full Text] [Related]  

  • 16. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Martinez-Useros J; Moreno I; Fernandez-Aceñero MJ; Rodriguez-Remirez M; Borrero-Palacios A; Cebrian A; Gomez Del Pulgar T; Del Puerto-Nevado L; Li W; Puime-Otin A; Perez N; Soengas MS; Garcia-Foncillas J
    BMC Cancer; 2018 Feb; 18(1):144. PubMed ID: 29409457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathological evaluation after preoperative neoadjuvant treatment in rectal cancer].
    Niu D; Xue W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jun; 21(6):632-636. PubMed ID: 29968237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Predictive Factors of Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation Therapy.
    Kokaine L; Gardovskis A; Gardovskis J
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of Endoscopy as a Predictive Factor when Evaluating the Clinical Response to Neoadjuvant Chemoradiotherapy for Patients with Rectal Cancer.
    Bengulescu I; Radu P; Iorga C; Bratucu M; Pasnicu C; Garofil D; Popa F; Strambu V
    Chirurgia (Bucur); 2020; 115(3):373-379. PubMed ID: 32614293
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal wait between long-course neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: a dilemma.
    Aggarwal G; Roy MK; Banerjee S
    ANZ J Surg; 2014; 84(1-2):4-5. PubMed ID: 24616925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.